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ABSTRACT
Bioinformatic analysis of the putative nuclease
domain of the single polypeptide restriction–
modification enzyme LlaGI reveals amino acid
motifs characteristic of the Escherichia coli
methylated DNA-specific Mrr endonuclease. Using
mutagenesis, we examined the role of the con-
served residues in both DNA translocation and
cleavage. Mutations in those residues predicted to
play a role in DNA hydrolysis produced enzymes
that could translocate on DNA but were either
unable to cleave the polynucleotide track or had
reduced nuclease activity. Cleavage by LlaGI is not
targeted to methylated DNA, suggesting that the
conserved motifs in the Mrr domain are a conven-
tional sub-family of the PD-(D/E)XK superfamily of
DNA nucleases.
INTRODUCTION
The nucleolytic cleavage of DNA is central to a great
many biological events and a wide diversity of enzyme
folds and motifs have evolved to undertake this task
(1–9). Many of these nuclease domains are encountered
in the bacterial and archaeal restriction–modiﬁcation
(RM) enzymes (10), studies of which have played a key
role in understanding nuclease mechanism (11). Amongst
the diﬀerent classes of RM enzyme, the Type II RM
enzymes show the widest diversity with at least ﬁve
unrelated structural folds identiﬁed (5): the PD-(D/
E)XK superfamily (also known as Superfamily I), which
accounts for the majority of RM enzymes; the HNH
superfamily; the phospholipase D (PLD) superfamily of
phosphodiesterases; the GIY-YIG superfamily; and a
novel ‘half-pipe’ (HP) fold. Whilst the PD-(D/E)XK,
HNH and GIY-YIG superfamilies are all dependent on
divalent metals, the PLD and HP families are not (12,13).
The Type I and III RM nuclease domains are less diverse,
reﬂecting in part the classiﬁcation of these enzymes
which groups them principally on the basis of similar
domain/subunit architecture: the Type I enzymes contain
variations on the RecB nuclease-family (14,15) and the
Type III enzymes contain variations of the Archaeal
Holliday Junction Resolvase (AHJR) family (16), both
being sub-families of Superfamily I (Ref. 1). All Type I
and III nucleases are believed to be Mg
2+-dependent.
ATP hydrolysis is required for DNA cleavage but this is
linked to the structurally distinct helicase domains in these
proteins (17,18).
The LlaGI RM enzyme is a single polypeptide enzyme
that comprises four domains (Figure 1A) (19): a nuclease;
a helicase; an adenine methyltransferase (MTase); and
target recognition domain (TRD). DNA cleavage occurs
at a random non-speciﬁc site and requires the interaction
of at least two LlaGI enzymes bound at distant DNA sites
(20). Long-range interaction is facilitated by a 1-D loop
translocation mechanism (21). Previous bioinformatic
analysis suggested that LlaGI contains a putative classical
PD-(D/E)XK motif typical of the nuclease domain of clas-
sical Type I enzymes (19). We show here that LlaGI and
related Type ISP enzymes actually contain a nuclease
domain most related to a sub-group of the AHJR
family as exempliﬁed by the Escherichia coli methylated
DNA-speciﬁc Mrr endonuclease.
MATERIALS AND METHODS
LlaGI sequence analysis
Amino acid sequences were obtained from REBASE (10)
and were selected from the list of Type IIG enzymes on
the basis of the presence of helicase motifs and on their
size (all sequences >150kDa being selected). (Note: all
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REBASE as being Type IIG due to their RM gene
arrangement). Of these, two distinct groupings were
noted on the basis of characteristic Walker A box
sequences in their helicase domains: those with a
GTGKT sequence (56 members including LlaGI) and
those with an RFGKT sequence (14 members) (see
Table 1 in ref. 20). The RFGKT group were not used
further in this analysis and will be considered elsewhere.
Sequence alignments of 54 of the GTGKT group were
carried out using ClustalW [(22); http://www.ebi.ac.
uk/Tools/clustalw/index.html; two sequences were dis-
carded because of extensive N-terminal deletions].
Manual realignments were made using Jalview (23)
before the ﬁnal alignments were submitted to JPred (24)
to predict average secondary amino acid structure. The
LlaGI sequence was also submitted separately to JPred.
Consensus sequences were calculated from the full align-
ment at: http://coot.embl.de/Alignment//consensus.html.
Mutagenesis and protein puriﬁcation
Plasmids pRSFLlaGI-E38A, -D74A, -D78A, -E82A,
-Q92A, -K94A, -K102A and -E104A were generated
by QuikChange mutagenesis using as the template
pRSFLlaGI (Ref. 20). The oligonucleotide sequences
used are available upon request. The LlaGI mutants
were puriﬁed following the wild-type protocol as described
in Smith et al (20). The protein concentration was deter-
mined by the Bradford dye-binding procedure (Bio-Rad
Protein Assay, Bio-Rad, Hemel Hempstead, UK) using
bovine serum albumin (BSA) as a standard (20). Each
mutant was then compared with the wild type by densito-
metry following SDS-gel electrophoresis and staining with
colloidal protein stain.
DNA translocation and cleavage assays
Translocation and cleavage assays were carried out as
described in the accompanying papers (20,21).
RESULTS AND DISCUSSION
Identiﬁcation of an Mrr nuclease motif in LlaGI
To identify the nuclease fold in LlaGI, we aligned
the amino acid sequences of 54 LlaGI-related enzymes
(a subset of which are shown in Figure 1B) (see
‘Materials and Methods’ section). This identiﬁed a three
motif consensus sequence and predicted secondary struc-
ture most similar to that found in the methylation-speciﬁc
endonuclease Mrr (Figure 1C) (8,9) which is deﬁned as
part of a larger AHJR subfamily (1). This classiﬁcation
of LlaGI-like enzymes into the Mrr-family has been noted
previously on the basis of randomized alignment searches
(1,8,9). It contrasts with the classiﬁcation of the LlaGI
nuclease domain made on the basis of alignment with
Type I and III enzymes which identiﬁed a putative classi-
cal PD-(D/E)XK motif (Figure 1D) (19). Whilst this motif
is found in enzymes with close similarity to LlaGI, it is not
conserved across the whole group. Moreover, the position
of the PD-(D/E)XK motif is not in the correct register
with the predicted secondary structure elements that
make up the nuclease abba core (Figure 1D) (2). The
register of the putative Mrr motifs in LlaGI matches more
closely the predictions for E. coli Mrr made on the basis of
the homology models (Figure 1C) (8,9). Both motifs of
LlaGI are tested below.
What is the role of each of the residues in the Mrr
motif? Surprisingly little is known of the molecular mech-
anism of Mrr, and the only mutagenesis studies of the
nuclease domain have used randomised in vivo screening
(9,25). The residues identiﬁed by these screens coincide
with a subset of the key residues identiﬁed in the
alignments, as well as more weakly conserved features
that are likely to have structural rather than catalytic
roles (Figure 1C and E) (9). Molecular models based on
sequence alignments, homology modelling and threading
onto BglII, suggest that Mrr has the characteristic abba
fold that arranges the nuclease motifs into a metal
ion–DNA binding pocket (Figure 1E) (8,9). We can
therefore use knowledge gained from the study of other
PD-(D/E)XK family RM enzymes to predict the roles of
the Mrr motifs.
In the prototypical version of the PD-(D/E)XK fold,
two acidic residues and a lysine from Motifs II and III
form a catalytic triad involved in divalent metal ion
binding and/or catalysis (11). The aspartate residue of
Motif II (corresponding to D78 of LlaGI, Figure 1B and
D) is the only invariant residue across Superfamily I (1).
It is preceded by a hydrophobic residue (I202 in Mrr,
Figure 1C and E; V77 in LlaGI, Figure 1B and D, but
more commonly Proline in Type II RM enzymes). LlaGI
and the Mrr-related enzymes contain a supplementary
aspartate that is 100% conserved, four amino acids
N-terminal to the catalytic aspartate and linked via a
conserved glycine (Figure 1A–C) (8,9). This residue does
not superimpose with any other conserved residue within
the superfamily (1), and in the structural model appears
to point away from the catalytic triad (D199 in Mrr,
Figure 1C and E, D74 in LlaGI, Figure 1B and D) (9).
The lysine residue of Motif III (K221 in Mrr, Figure 1C
and E; K94 in LlaGI, Figure 1B and D) corresponds to the
catalytic residue typical of Superfamily I [although it is
exchanged with aspartate or glutamate in some Type II
RM enzymes; (11)]. However, the signature Motif III
glutamate acidic residue is replaced in all LlaGI- and
Mrr-like enzymes with a glutamine (Q219 in Mrr,
Figure 1C and E, Q92 in LlaGI, Figure 1B and D).
A number of diﬀerent non-canonical versions of the
PD-(D/E)XK fold can be categorized by the replacement
of the acidic residue in Motif III (11,26–34). In these cases,
the ‘missing’ residue is substituted by the presence of alter-
native carboxylate residues from elsewhere in the primary
sequence that contribute to the catalytic/metal binding site
(2,11,29). This highlights that spatial conservation of
residues is important rather than sequence conservation
per se (29). In Type II RM enzymes Cfr10I, NgoMIV,
and Bse634I, where a serine or glycine replaces the
conserved acidic residue, a distal glutamate found in the
a-helix C-terminal to Motif III plays the substituting role
(26–28,30). In Type II RM enzymes SsoII and PspGI,
where a serine or threonine replaces the conserved acidic
7232 Nucleic Acids Research, 2009,Vol.37, No. 21Figure 1. Mrr nuclease motifs in the LlaGI RM enzyme. (A) Cartoon of LlaGI with domains indicated. The locations of the Mrr nuclease Motifs I,
II and III are shown in Black. Additional residues tested here are shown in grey. SF2 is Superfamily 2. (B) Multiple alignment of amino acid
sequences of the LlaGI-like family (11/54 sequences shown). Alignments were carried out using ClustalW (22) and secondary structure predictions
were made by JPred (24) using the full alignment. Consensus sequences were also calculated using the full alignments. For further details, please refer
to ‘Materials and Methods’ section. Each protein is identiﬁed by the gene name as given in REBASE (10). Numbers to the left indicate the number
of N-terminal residues truncated. Poorly conserved regions are replaced by numbers indicating the residues omitted. Red highlighting indicates
sequences with >95% identity and black highlighting indicates sequences with >85% identity. Grey highlighting indicates sequences with 70–81%
identity that could be accessory catalytic residues. The predicted secondary structure is shown above the alignments with H for an a-helix and E for a
b-strand. The 90% consensus is shown below the alignment with the following key: t, turnlike (ACDEGHKNQRST); h, hydrophobic
(ACFGHIKLMRTVWY); l, aliphatic (ILV); a, aromatic (FHWY); p, polar (CDEHKNQRST); c, charged (DEHKR); o, alcohol (ST); and, s,
small (ACDGNPSTV). Residues in bold and underlined are 100% conserved. Three of the twelve LlaGI-like sequences from Bartonella tribocorum
CIP 105476 are shown as examples of inactivation of the nuclease motif by mutation of Motif III (BtrCIPORF541P) or truncation of Motif I
(BtrCIPORF14P). (C) Mrr sequences from E. coli and S. typhimurium LT2. The synaptomorphic Mrr residues are shown in bold. The secondary
structure was calculated from the E. coli Mrr model (9), and the numbering is shown as in (B). The green, red and purple boxes refer to the colouring
of secondary structure elements in (E). Residues identiﬁed from in vivo screens as important (9,25) are indicated by hash marks. (D) LlaGI sequences
showing the Mrr motifs identiﬁed here (upper sequence, highlighted in red and black) and the PD-(D/E)XK motifs identiﬁed previously (19) (lower
sequence, highlighted in blue). Mutations made in this study are marked with an asterisk. The secondary structure was predicted for the LlaGI
sequence alone using JPred (24) and is labelled as in (B). (E) Amino acids 160–250 of the structural model of E. coli Mrr (ftp://genesilico
.pl/iamb/models/Mrr/) (9). Amino acids in the brackets refer to the equivalent residues in LlaGI. Secondary structure colouring refers to (C).
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in the adjacent a-helix, each of which support cleavage
with both required for maximal activity (31,32). In the
homology model structure of Mrr (Figure 1E), E231
from the a-helix C-terminal to Motif III points towards
the D203 and K221 residues of Motifs II and III and it has
been suggested this replaces the ‘missing’ carboxylate at
residue Q219 (9). Whilst this residue shows some conser-
vation amongst enzymes most closely related to E. coli
Mrr (8,9), the LlaGI-family show much greater variability
in this region (Figure 1B), apart from a strongly conserved
phenylalanine that most likely plays a structural role
(F108 in LlaGI, Figure 1B). LlaGI contains a single glu-
tamate (E104) similarly placed to the Mrr E231 residue.
A nearby lysine residue (K102) is also present in 81% of
the LlaGI-like sequences. Either or both of these residues
may play a role in the catalytic site similar to the
suggestions for the Type II enzymes described above (29).
In the PD-(D/E)XK fold, the glutamate at Motif I is
strongly conserved. However, the exact function of this
acidic residue is still a matter of debate, with suggested
roles, for example, in stabilizing metal ion binding (1,11),
in acting as a general base in catalysis (35) or in facilitating
conformational transitions on-pathway to the coordina-
tion of the catalytic triad (36). Mutations at this residue
in some enzymes knock out nuclease activity to a similar
extent as mutations in the catalytic triad (37,38). In
contrast, in other enzymes comparable mutations cause
only a partial reduction in activity, suggesting a more
peripheral role (39–41). In many of the Superfamily I
enzymes the helix containing Motif I also has a small
residue (G or P) N-terminal to the conserved glutamate
that most likely allows ﬂexibility/a kink that is structurally
important (1). In the Mrr homology model, E172 from
Motif I is located close to D203 of Motif II, consistent
with the roles described above (9). The equivalent residue
in LlaGI is E38 (Figure 1B). An adjacent phenylalanine
residue is conserved across all Mrr-like enzymes and
is likely to play a structural role (1,8,9). Glycine and
tyrosine residues at the C-terminus of the Motif I helix
have been identiﬁed as important by in vivo screens of
E. coli and Salmonella typhimurium LT2 Mrr (9,25).
However, equivalent residues are not conserved across
the LlaGI-like enzymes.
Mutagenesis of the LlaGI nuclease motifs and analysis
of DNA translocation activity
To ﬁnd out which of the conserved residues of LlaGI
contribute to nuclease activity, alanine substitutions
were made in Mrr Motif I (E38A), Mrr Motif II (D74A
and D78A), putative PD-(D/E)XK Motif III (E82A), Mrr
Motif III (Q92A and K94A) and the putative accessory
residues (K102A and E104A) (Figure 1D). The nuclease
residues were mutated in pRSFLlaGI using the
QuikChange mutagenesis protocol (see ‘Materials and
Methods’ section). The wild type and mutant LlaGI
enzymes were puriﬁed as described in the accompanying
paper (Figure 2) (20); the mutants behaved as wild type
during expression and puriﬁcation (data not shown), with
the exception of K102A which gave a reduced yield.
We ﬁrst compared the ability of the mutant LlaGI
enzymes to translocate on linear DNA. This was carried
out using a triplex displacement assay as described in
Smith et al., (21) with a saturating protein concentration.
Figure 3A shows the triplex displacement proﬁles for the
1977-bp spacing for wild-type LlaGI and all eight nuclease
mutants. The proﬁles are those expected for dsDNA
translocation, with a lag phase and an exponential dis-
placement phase. Displacement proﬁles were obtained
for a further three triplex spacings and the lag times
calculated (see ‘Materials and Methods’ section) (21,42).
From these we obtained the linear relationship between
distance and lag time from which we could calculate
translocation rates (Figure 3B). All of the mutant LlaGI
enzymes showed translocation kinetics consistent with the
wild-type enzyme, indicating that the mutations had not
had a detrimental eﬀect on gross structure and that the
nuclease domain is unlikely to play a direct role in
translocation. However, we have shown previously for
the Type I RM enzyme EcoR124I that whilst nuclease
mutations can have no apparent eﬀect on translocation
as judged by the ensemble triplex assay, increased static
disorder in the mutant enzyme population can cause
stalling events that are only observed in single molecule
assays (43). Examination of the exponential phases of the
triplex displacement proﬁles showed variations that could
be interpreted as changes in the distribution of the enzyme
population during translocation (42). However, the
diﬀerences were not consistent between diﬀerent DNA
spacings and did not show any relationship with subse-
quent kinetic data. That is, some mutants had wild-type-
like cleavage properties despite having slower second
phase exponential proﬁles on some DNA. We therefore
suggest that the diﬀerences in the proﬁles most likely rep-
resent experimental error and that all mutants have wild-
type-like translocation activity under the saturating
enzyme concentrations used here.
DNA cleavage properties of the LlaGI nuclease
domain mutants
In the subsequent assays, we tested DNA cleavage activ-
ity using a DNA substrate containing two indirectly
repeated sites [pHH-3, (20)]. Figure 4 shows the extent
Figure 2. Puriﬁcation of LlaGI mutants. SDS polyacrylamide gel
showing 1.5mg of LlaGI wild type and mutants following the gel
ﬁltration puriﬁcation step. See ‘Materials and Methods’ section for
full details.
7234 Nucleic Acids Research, 2009,Vol.37, No. 21of DNA cleavage after extensive incubation with an excess
of each LlaGI enzyme. On the basis that, under these
conditions, the wild-type enzyme cleaves close to 100%
of the substrate to produce >95% linear DNA and that
all proteins are active for translocation, we can identify
three diﬀerent enzyme groups with either: (i) full nuclease
activity (>95% linear produced), including wild type
(Figure 4, lane 2), E82A (lane 6), E104A (lane 9) and
K102A (lane 10); (ii) no nuclease activity, including
D74A (lane 4), D78A (lane 5) and K94A (lane 8); or,
(iii) partial/reduced nuclease activity (signiﬁcant amounts
of nicked DNA remaining at the end of the reaction),
including E38A (lane 3) and Q92A (lane 7). To assess
further the endonuclease mechanism of the active and
partially active mutants, we measured the extent of
DNA cleavage at the reaction ‘end point’ as a function
of the LlaGI:DNA molecular ratio and measured the
rate of DNA cleavage at a saturating concentration of
LlaGI.
LlaGI nuclease mutants with wild-type activity. The ‘clas-
sical’ PD-(D/E)XK motif identiﬁed by alignment of LlaGI
with representative Type I and III enzymes (Figure 1D)
(19) was tested by mutating residue E82 that corresponds
to the archetypical essential acidic residue of Motif III.
Both the cleavage titration (Figure 5A, upper panel) and
cleavage time-course (lower panel) are characteristic of
wild-type activity (compare to Figure 6A and D in ref.
20), indicating that it is unlikely that E82 plays any role
in the nuclease active site. This is consistent with the full
alignment data which does not identify the PD-(D/E)XK
motif as conserved (Figure 1B) or correctly aligned with
the predicted secondary structure elements (Figure 1D).
The correct identiﬁcation of the nuclease motifs is
relatively challenging as the sequence similarity between
active sites is relatively low. A similar case of mistaken
identity was also made with the homing endonuclease
I-PpoI, which displays a sequence resembling a PD-
(D/E)XK motif but which actually plays no role, the
enzyme instead using an unrelated His–Cys box motif
(44,45).
A residue that could act as a catalytic replacement for
the missing acidic residue in Motif III is E104. However,
E104A had titration and kinetic proﬁles very similar to
the wild-type protein and distinct from those of Q92A
or E38A (Figures 4 and 5B). We therefore suggest that
E104 plays little or no role in the LlaGI cleavage
activity. The partially conserved lysine residue K102 in
the a-helix C-terminal to Motif III was also tested and
shown to have wild type activity (Figure 4; data not
shown). An equivalent conserved lysine residue is not
observed in the bona ﬁde Mrr protein alignment (8,9)
and this region shows virtually no sequence conservation
across Superfamily I (1). Although individual nuclease
sub-families are likely to have important synaptomorphic
residues, in this study we could not ﬁnd any speciﬁc role
for K102 or E104 in LlaGI activity.
Figure 3. DNA translocation by the nuclease mutants of LlaGI. (A) Representative triplex displacement proﬁles. DNA (RMA03F at 1nM) with the
1977-bp spacing triplex bound (0.5nM) were pre-incubated with LlaGI (10nM) and translocation initiated by mixing with 4mM ATP. (Inset)
Expanded portion of the exponential phase as indicated. Proﬁles at three other triplex spacings were also collected for each protein (data not shown).
See text for further details. (B) Translocation rates (kstep) determined from the lag times of the triplex displacement proﬁles [(A) and data not shown].
Error bars represent the standard error of the linear ﬁt of the lag times to distance. Reactions were carried out and analysed as in the accompanying
paper (21).
Figure 4. Summary of the DNA cleavage properties of LlaGI and the
nuclease mutants; 4nM pHH-3 was incubated with 200nM LlaGI (or
100nM LlaGIK102A) as indicated, plus 4mM ATP for 10min. DNA
substrates (CC, covalently closed circular DNA), intermediates (OC,
open circle) and products (FLL, full-length linear) were separated by
agarose gel electrophoresis.
Nucleic Acids Research, 2009,Vol.37, No. 21 7235LlaGI nuclease mutants with no nuclease activity. The
principal residues of Motifs II and III that have equiva-
lents across Superfamily I are D78 and K94. Alanine
substitutions at either position were completely inactive
over one hour incubation, irrespective of the protein
concentration used (Figure 4, data not shown). These
observations are consistent with the important metal ion
binding and catalytic roles identiﬁed for these residues in
Superfamily I proteins (11). It also corroborates the in vivo
screening data for Mrr that identiﬁed the I-D residues of
Motif III (V-D in LlaGI) as being critical (Figure 1C) (25).
Strikingly, we also found that alanine substitution at
D74 in Motif II was completely inactive (Figure 4, data
not shown). This conserved residue is a synaptomorphic
marker of the Mrr enzymes that does not appear in any
other sub-group of Superfamily I (1). The structural
models for Mrr have not identiﬁed a direct role for this
residue in catalysis (Figure 1E) (8,9). Since the LlaGI
cleavage pathway is complex, preceded by many diﬀerent
steps [binding, loop initiation, ATPase, translocation, col-
lision, activation, etc, (21)], we cannot rule out that the
nuclease domain retains some weak activity but that the
collision complex collapses before a strand break can
occur.
LlaGI nuclease mutants with partial nuclease activity. The
Q92A mutation in Motif III showed reduced activity
in both the titration and kinetic analysis (Figure 5C).
An elevated concentration of Q92A was still unable to
completely cleave the CC DNA compared to WT
enzyme (Figure 5C, upper panel). Very little nicked
DNA intermediate accumulated during the titrations.
During the DNA cleavage time course under saturated
conditions, a ﬁrst strand cleavage rate that was more
than 10-fold slower than wild type was followed by a
signiﬁcantly slower second strand cleavage resulting in
the accumulation of nicked DNA to >80% of the total
DNA (Figure 5C, lower panel). Both these observations
may reﬂect a weaker association of the nuclease active site
with the DNA. Our data suggests that whilst Q92 does
not play a critical catalytic role, it may have a secondary
structural role in stabilizing the active site on the DNA.
A similar role has been suggested for a conserved
glutamine that is part of the RecB-family nuclease fold
of classical multi-subunit Type I RM enzymes (15).
The E38A mutation in Motif I also showed reduced
activity with titration and kinetic proﬁles very similar to
Q92A (Figure 5D). Again the data are consistent with a
non-critical yet important secondary role in the active site
(11). Partial nuclease activity of Motif I mutants has also
been seen with Type II RM enzymes [e.g. E45A of EcoRV
(39,40) and E55A of PvuII (41)], reﬂecting this secondary
role. We can however rule out the glutamate of Motif I as
being the replacement residue in LlaGI for the missing
acidic residue of Motif III (34).
CONCLUSIONS
The in vitro analysis of the LlaGI nuclease mutants is con-
sistent with the bioinformatic analysis; i.e. residues in the
Mrr-family Motifs I, II and III that are >90% conserved
are important for cleavage activity, with D74, D78 and
K94 being critical. The changes in DNA cleavage
activity cannot be put down to ineﬃcient translocation
as all the mutants had triplex displacement properties
similar to wild type. We cannot, however, state whether
these mutants had altered DNA-binding properties as our
assays were all undertaken using saturating enzyme
concentrations. The previously identiﬁed PD-(D/E)XK
motif (19), was shown to be both non-essential and not
conserved across the LlaGI-like enzyme family. Previous
studies of Type II RM enzymes with a (D/E)(S/T/A/G)
substitution at Motif III have identiﬁed putative replace-
ment acidic residues in the a-helical region immediately
C-terminal to Motif III (26–34). The structural model of
Mrr predicts that a similar residue in a similar location
Figure 5. Stoichiometry and rate of DNA cleavage by LlaGI mutants. Points are the mean of at least two repeat experiments. Note that where
the FLL product becomes smeared due to end-processing, this can cause an overestimation of the CC band which overlaps with the smear.
(Upper panels) pHH-3 was incubated with the LlaGI mutants at the concentrations indicated for 1h. (Lower panels) Time course of cleavage of
pHH-3 with a saturating concentration (200nM) of the LlaGI mutants. Reactions were carried out and analysed as in the accompanying paper (20).
7236 Nucleic Acids Research, 2009,Vol.37, No. 21plays a similar role (E231, Figure 1E) (8,9). However, we
were unable to identify a residue in this structural region
that could play a critical role in the cleavage mechanism
of LlaGI. This suggests that either: (i) A currently
unidentiﬁed residue from elsewhere in the sequence plays
an important role; or (ii) the Motif I, II and III residues
are suﬃcient for activity. It is notable that our study
highlights D74 as absolutely required for catalysis. This
Motif II residue is 100% conserved across Mrr-family
enzymes but is not seen in any other sub-group of
Superfamily I (1). It may be that the secondary aspartate
of Motif II supplements for the glutamine in Motif III and
forms the catalytic triad (in apparent contradiction with
the Mrr homology models).
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